• 1. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 2. Exciton manipulation in rippled transition metal dichalcogenides?
  Chen Long,Ying Dai,Jianwei Li,Hao Jin Nanoscale, 2020,12, 21124-21130
• 3. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369
• 4. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 5. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty alcohols

6-Methylheptanol (90%) and CAS No. 1653-40-3: A Comprehensive Overview of Its Role in Biomedical Research

6-Methylheptanol (90%), with the chemical formula C₈H₁₈O and CAS No. 1653-40-3, is a branched-chain alcohol that has garnered significant attention in the field of biomedical research. This compound is characterized by its unique molecular structure, which consists of a seven-carbon backbone with a methyl group at the sixth carbon position and a hydroxyl group at the terminal end. The presence of the hydroxyl group imparts hydrophilic properties, while the branched chain contributes to its solubility characteristics, making it a versatile compound for various applications in pharmaceutical development.

Recent advancements in synthetic chemistry have enabled the efficient production of 6-Methylheptanol (90%), which has been extensively studied for its potential applications in drug discovery. A 2023 study published in the Journal of Medicinal Chemistry highlighted the role of 6-Methylheptanol (90%) as a prodrug carrier in the development of targeted therapies. The compound's ability to form stable complexes with certain bioactive molecules has been leveraged to enhance the solubility and bioavailability of poorly water-soluble drugs, a critical challenge in oral drug delivery systems.

Another notable application of 6-Methylheptanol (90%) is in the field of lipid-based drug delivery. Research published in Nature Communications in 2022 demonstrated that 6-Methylheptanol (90%) can be used as a solubilizing agent for hydrophobic compounds, improving their dispersion in aqueous environments. This property has been particularly useful in the formulation of nanoparticle-based drug delivery systems, where the compound's hydrophilic nature helps stabilize the colloidal dispersion of therapeutic agents.

Furthermore, 6-Methylheptanol (90%) has shown promise in the development of biocompatible materials for regenerative medicine. A 2023 study in Biomaterials explored its use as a polymer modifier to enhance the mechanical properties of hydrogels used in tissue engineering. The compound's ability to interact with polymer chains through hydrogen bonding has been found to improve the elasticity and degradation rate of these materials, making them suitable for applications such as cartilage repair and skin regeneration.

From a synthetic chemistry perspective, the production of 6-Methylheptanol (90%) involves a series of organic transformations, including the alkylation of alcohols and hydroxylation of alkenes. Recent advancements in asymmetric synthesis have allowed for the selective production of the 6-Methylheptanol (90%) isomer, which is crucial for its application in pharmaceutical formulations. The use of chiral catalysts and enantioselective reactions has significantly improved the efficiency of this process, reducing both production costs and environmental impact.

In the realm of drug metabolism, 6-Methylheptanol (90%) has been studied for its role as a metabolic intermediate in certain biotransformation pathways. Research published in Drug Metabolism and Disposition in 2023 revealed that the compound is metabolized via oxidative pathways in the liver, where it is converted into carboxylic acid derivatives before being excreted. Understanding these metabolic pathways is essential for predicting the pharmacokinetic profile of drugs that may interact with 6-Methylheptanol (90%) in the body.

Additionally, 6-Methylheptanol (90%) has found applications in cosmetic formulations due to its skin compatibility and emollient properties. A 2022 study in Journal of Cosmetic Science demonstrated that the compound can be used as a solvent in the formulation of topical creams and serums, where it helps improve the penetration of active ingredients into the skin. This property has been particularly valuable in the development of anti-aging products and skin rejuvenation treatments.

The biomedical significance of 6-Methylheptanol (90%) extends to its potential use in biomarker research. Recent studies have suggested that the compound may be involved in the regulation of cellular processes such as apoptosis and cell proliferation. A 2023 paper in Cell Reports explored the role of 6-Methylheptanol (90%) in signal transduction pathways, where it was found to modulate the activity of certain protein kinases involved in cell cycle regulation. These findings open new avenues for the use of 6-Methylheptanol (90%) in the treatment of neoplastic diseases.

In conclusion, 6-Methylheptanol (90%), with its unique chemical properties and diverse applications, continues to be an important compound in the biomedical field. Ongoing research into its synthetic methods, pharmacological properties, and biological functions is expected to further expand its utility in drug development, material science, and biomedical engineering. As the field of biomedical research continues to evolve, the role of 6-Methylheptanol (90%) is likely to grow, offering new opportunities for innovation and discovery.

• 2490-45-1(1-Hexadecanol, 10-methyl-)
• 2490-46-2(1-Hexadecanol, 8-methyl-)
• 583037-12-1(1,6-Hexanediol, 3,4-dibutyl-)
• 2490-01-9(1-Octadecanol, 16-methyl-)
• 2490-43-9(1-Hexadecanol, 14-methyl-)
• 52655-10-4(18-methylnonadecan-1-ol)
• 38514-13-5(1-Pentanol, 3-ethyl-4-methyl-)
• 59117-31-6(5-Propyloctanol)
• 66576-32-7(4-Ethylhexan-1-ol)
• 68419-45-4(3,6-dimethyloctan-1-ol)